India backs EMA's exposure limit for drug production in shared venues

02/4/2013 | PharmaBiz.com (India)

Indian drugmakers support the European Medicines Agency's guideline on health-based exposure restrictions for use in ascertaining the risks of making different treatments, such as cytotoxic drugs, hormones or antibiotics, in the same plant, according to a regional drug manufacturing group.

View Full Article in:

PharmaBiz.com (India)

Published in Briefs: